Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia, lovotibeglogene autotemcel for the treatment of sickle cell disease and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy.
The company’s clinical study program includes HGB-205, HGB-206 and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207 and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics, Forty Seven and Magenta Therapeutics.
For Bluebird Bio stock, Baird has a $9 target price. The consensus target is $7.20, and shares traded on Friday at $6.80.
Diebold Nixdorf
The nation’s top banks are big customers of this company’s products. Diebold Nixdorf Inc. (NYSE: DBD) provides connected commerce solutions to financial institutions and retailers in Europe, Asia, the Middle East, Africa, the North America and Latin America.
The company offers cash recyclers and dispensers, intelligent deposit terminals, teller automation tools and kiosk technologies, as well as physical security solutions. It also offers front-end applications for consumer connection points and back-end platforms that manage channel transactions, operations and integration, and facilitate omnichannel transactions, endpoint monitoring, remote asset management, customer marketing, merchandise management and analytics.
Diebold Nixdorf also provides banking productelated services, comprising proactive monitoring and rapid resolution of incidents through remote service capabilities or an on-site visit; first- and second-line maintenance, preventive maintenance and on-demand services; managed and outsourcing services, such as business processes, solution management, upgrades and transaction processing; and cash management services.
In addition, the company offers DN Vynamic software suite to simplify and enhance the consumer experience; mobile point of sale and self-checkout terminals; printers, scales and mobile scanners; and banknote and coin processing systems. It provides retail customers productelated services, such as on-demand and professional services; maintenance and availability services; implementation services; managed mobility services; monitoring and advanced analytics; and store life-cycle management services.
Wedbush’s $5 target price is less than the $5.67 consensus target. Diebold Nixdorf stock traded on Friday at $4.25.
Rackspace Technology
This company returned to the publicly traded markets a few years ago after a stint in private equity land. Rackspace Technology Inc. (NYSE: RXT) operates as a multicloud technology services company worldwide.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
